英文名稱 | Glecaprevir | ABT-493 | A 1282576 |
---|---|
中文名稱 | 格來普韋 |
CAS號 | 1365970-03-1 |
分子式 | C38H46F4N6O9S |
分子量 | 838.87 |
外觀 | White to off-white powder |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
英文名稱 | Glecaprevir | ABT-493 | A 1282576 |
---|---|
中文名稱 | 格來普韋 |
CAS號 | 1365970-03-1 |
分子式 | C38H46F4N6O9S |
分子量 | 838.87 |
外觀 | White to off-white powder |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Glecaprevir (previously called ABT493; A1282576;ABT-493; A-1282576;Mavyret) is a novel and potent inhibitor of thehepatitis C virus nonstructural protein 3/4A protease (HCV NS3/4A) approved as anti-HCV drug in co-formulation with an HCV NS5A inhibitor pibrentasvir.